Establishment and characterization of fetal equine kidney and lung cells with extended lifespan. Susceptibility to equine gammaherpesvirus infection and transfection efficiency.
- Journal Article
Summary
This research article discusses the development and analysis of long-lasting equine kidney and lung cells to study equine gammaherpesvirus infection and its effect on transfection efficiency.
Extended Lifespan of Equine Cells
The researchers generated equine cells with a prolonged lifespan from primary equine fetal kidney and lung cells. The process involved:
- Transfection of the cells with a retroviral vector (LXSN116E6E7) which contains human papilloma virus oncogenes 16 E6 and E7.
- This technique extended the propagation lifespan of the transfected equine kidney and lung cell lines beyond 40 passages. Notably, the primary cells could be propagated only for 10-12 passages.
Susceptibility to Equine Gammaherpesvirus
The article also discusses the susceptibility of these cells to equine gammaherpesvirus, specifically the EHV-2 strain. The key findings include:
- The primary cells and their derived cell lines were infected with EHV-2 with similar efficiency.
- The kidney cell line could be infected by EHV-5 to a significantly higher level than its primary cell counterpart, indicating higher susceptibility.
- The infected kidney cells showed cytopathic effects three days earlier than the primary cells.
- However, the lung cell line was not ideal for virus production due to its rapid growth.
Transfection Efficiency
The research assesses the efficiency at which these cells could be transfected with foreign DNA. It reveals that:
- The kidney cell line was four times more susceptible to transfection than the primary kidney cells.
- Interestingly, no significant difference was observed between the lung cell line and primary lung cells in terms of transfection efficiency.
Potential Applications
The researchers suggest that these new equine cell lines can be a valuable tool for studying gammaherpesviruses, and potentially, other viruses that infect horses. By enabling an extended cell lifespan and high transfection efficiency, this development could significantly enhance research into equine virology.
Cite This Article
Publication
Researcher Affiliations
- Institute for Experimental Pathology, University of Iceland, Keldur, Keldnavegur 3, 112, Reykjavík, Iceland. liljatho@hi.is.
- Institute for Experimental Pathology, University of Iceland, Keldur, Keldnavegur 3, 112, Reykjavík, Iceland.
- Institute for Experimental Pathology, University of Iceland, Keldur, Keldnavegur 3, 112, Reykjavík, Iceland.
MeSH Terms
- Animals
- Cell Line / virology
- Disease Susceptibility
- Gammaherpesvirinae / pathogenicity
- Herpesviridae Infections / pathology
- Herpesviridae Infections / veterinary
- Herpesviridae Infections / virology
- Horses
- Humans
- Kidney / cytology
- Kidney / virology
- Lung / cytology
- Lung / virology
- Transfection
References
- Murray MJ, Eichorn ES, Dubovi EJ, Ley WB, Cavey DM. Equine herpesvirus type 2: prevalence and seroepidemiology in foals.. Equine Vet J 1996 Nov;28(6):432-6.
- Thorsteinsdóttir L, Torfason EG, Torsteinsdóttir S, Svansson V. Genetic diversity of equine gammaherpesviruses (γ-EHV) and isolation of a syncytium forming EHV-2 strain from a horse in Iceland.. Res Vet Sci 2013 Feb;94(1):170-7.
- Wang L, Raidal SL, Pizzirani A, Wilcox GE. Detection of respiratory herpesviruses in foals and adult horses determined by nested multiplex PCR.. Vet Microbiol 2007 Mar 31;121(1-2):18-28.
- Dunowska M, Holloway SA, Wilks CR, Meers J. Genomic variability of equine herpesvirus-5.. Arch Virol 2000;145(7):1359-71.
- Dynon K, Black WD, Ficorilli N, Hartley CA, Studdert MJ. Detection of viruses in nasal swab samples from horses with acute, febrile, respiratory disease using virus isolation, polymerase chain reaction and serology.. Aust Vet J 2007 Jan-Feb;85(1-2):46-50.
- Browning GF, Studdert MJ. Genomic heterogeneity of equine betaherpesviruses.. J Gen Virol 1987 May;68 ( Pt 5):1441-7.
- Sugahara Y, Matsumura T, Kono Y, Honda E, Kida H, Okazaki K. Adaptation of equine herpesvirus 1 to unnatural host led to mutation of the gC resulting in increased susceptibility of the virus to heparin.. Arch Virol 1997;142(9):1849-56.
- Diallo IS, Hewitson GR, de Jong A, Kelly MA, Wright DJ, Corney BG, Rodwell BJ. Equine herpesvirus infections in yearlings in South-East Queensland.. Arch Virol 2008;153(9):1643-9.
- Band V, Zajchowski D, Kulesa V, Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements.. Proc Natl Acad Sci U S A 1990 Jan;87(1):463-7.
- Thorsteinsdóttir L, Torfason EG, Torsteinsdóttir S, Svansson V. Isolation and partial sequencing of Equid herpesvirus 5 from a horse in Iceland.. J Vet Diagn Invest 2010 May;22(3):420-3.
- Bell SA, Balasuriya UB, Nordhausen RW, MacLachlan NJ. Isolation of equine herpesvirus-5 from blood mononuclear cells of a gelding.. J Vet Diagn Invest 2006 Sep;18(5):472-5.
- Torfason EG, Thorsteinsdóttir L, Torsteinsdóttir S, Svansson V. Study of equid herpesviruses 2 and 5 in Iceland with a type-specific polymerase chain reaction.. Res Vet Sci 2008 Dec;85(3):605-11.
- Allen GP, Bryans JT. Studies of an established equine cell line derived from a transitional cell carcinoma.. Am J Vet Res 1974 Sep;35(9):1153-60.
- Osterrieder N. Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant.. Virus Res 1999 Feb;59(2):165-77.
- Akula SM, Wang FZ, Vieira J, Chandran B. Human herpesvirus 8 interaction with target cells involves heparan sulfate.. Virology 2001 Apr 10;282(2):245-55.
- Sharp EL, Farrell HE, Borchers K, Holmes EC, Davis-Poynter NJ. Sequence analysis of the equid herpesvirus 2 chemokine receptor homologues E1, ORF74 and E6 demonstrates high sequence divergence between field isolates.. J Gen Virol 2007 Sep;88(Pt 9):2450-2462.
- Wazer DE, Liu XL, Chu Q, Gao Q, Band V. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7.. Proc Natl Acad Sci U S A 1995 Apr 25;92(9):3687-91.
- Maeda K, Kai K, Matsumura T. Genomic diversity among equine herpesvirus-4 field isolates.. J Vet Med Sci 2005 Jun;67(6):555-61.
- Dunowska M, Meers J, Wilks CR. Isolation of equine herpesvirus type 5 in New Zealand.. N Z Vet J 1999 Apr;47(2):44-6.
- Dunowska M, Howe L, Hanlon D, Stevenson M. Kinetics of Equid herpesvirus type 2 infections in a group of Thoroughbred foals.. Vet Microbiol 2011 Aug 26;152(1-2):176-80.
- Birkmann A, Mahr K, Ensser A, Yağuboğlu S, Titgemeyer F, Fleckenstein B, Neipel F. Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1.. J Virol 2001 Dec;75(23):11583-93.
- Borchers K, Wolfinger U, Goltz M, Broll H, Ludwig H. Distribution and relevance of equine herpesvirus type 2 (EHV-2) infections.. Arch Virol 1997;142(5):917-28.
- Brault SA, Bird BH, Balasuriya UB, MacLachlan NJ. Genetic heterogeneity and variation in viral load during equid herpesvirus-2 infection of foals.. Vet Microbiol 2011 Jan 27;147(3-4):253-61.
- Oguma K, Ishida M, Maeda K, Sentsui H. Efficient propagation of equine viruses in a newly established equine cell line, FHK-13.1 cells.. J Vet Med Sci 2013;75(9):1223-5.
- Gudjonsson T, Villadsen R, Nielsen HL, Rønnov-Jessen L, Bissell MJ, Petersen OW. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.. Genes Dev 2002 Mar 15;16(6):693-706.
- Craig MI, Barrandeguy ME, Fernández FM. Equine herpesvirus 2 (EHV-2) infection in thoroughbred horses in Argentina.. BMC Vet Res 2005 Nov 9;1:9.
Citations
This article has been cited 2 times.- Thorsteinsdóttir L, Guðmundsson GÖ, Jensson H, Torsteinsdóttir S, Svansson V. Isolation of equid alphaherpesvirus 3 from a horse in Iceland with equine coital exanthema. Acta Vet Scand 2021 Feb 2;63(1):6.
- Thorsteinsdóttir L, Jónsdóttir S, Stefánsdóttir SB, Andrésdóttir V, Wagner B, Marti E, Torsteinsdóttir S, Svansson V. The effect of maternal immunity on the equine gammaherpesvirus type 2 and 5 viral load and antibody response. PLoS One 2019;14(6):e0218576.